539 related articles for article (PubMed ID: 14559102)
1. Allosteric modulators of G-protein-coupled receptors.
May LT; Christopoulos A
Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
[TBL] [Abstract][Full Text] [Related]
2. Allosteric modulation of G protein-coupled receptors.
May LT; Avlani VA; Sexton PM; Christopoulos A
Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
[TBL] [Abstract][Full Text] [Related]
3. Allosteric modulation of G protein-coupled receptors.
May LT; Leach K; Sexton PM; Christopoulos A
Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
[TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled receptor allosterism: the promise and the problem(s).
Christopoulos A; May LT; Avlani VA; Sexton PM
Biochem Soc Trans; 2004 Nov; 32(Pt 5):873-7. PubMed ID: 15494038
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled receptor allosterism and complexing.
Christopoulos A; Kenakin T
Pharmacol Rev; 2002 Jun; 54(2):323-74. PubMed ID: 12037145
[TBL] [Abstract][Full Text] [Related]
6. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
Feng Z; Hu G; Ma S; Xie XQ
AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
[TBL] [Abstract][Full Text] [Related]
7. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
Lu S; Zhang J
J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
Reinecke BA; Wang H; Zhang Y
Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
Keov P; Sexton PM; Christopoulos A
Neuropharmacology; 2011 Jan; 60(1):24-35. PubMed ID: 20637785
[TBL] [Abstract][Full Text] [Related]
10. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
Persechino M; Hedderich JB; Kolb P; Hilger D
Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
[TBL] [Abstract][Full Text] [Related]
11. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
[TBL] [Abstract][Full Text] [Related]
12. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT; Watson J; Bertekap R; Alt A
Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
[TBL] [Abstract][Full Text] [Related]
13. Allosteric Modulators of the Class A G Protein Coupled Receptors.
Tschammer N
Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
[TBL] [Abstract][Full Text] [Related]
14. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
Valant C; Sexton PM; Christopoulos A
Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
[TBL] [Abstract][Full Text] [Related]
15. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
16. "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu
Hellyer SD; Albold S; Wang T; Chen ANY; May LT; Leach K; Gregory KJ
Mol Pharmacol; 2018 May; 93(5):504-514. PubMed ID: 29514854
[TBL] [Abstract][Full Text] [Related]
17. Rational design of dualsteric GPCR ligands: quests and promise.
Mohr K; Tränkle C; Kostenis E; Barocelli E; De Amici M; Holzgrabe U
Br J Pharmacol; 2010 Mar; 159(5):997-1008. PubMed ID: 20136835
[TBL] [Abstract][Full Text] [Related]
18. GPCR drug discovery-moving beyond the orthosteric to the allosteric domain.
Felder CC
Adv Pharmacol; 2019; 86():1-20. PubMed ID: 31378249
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders.
Wang L; Martin B; Brenneman R; Luttrell LM; Maudsley S
J Pharmacol Exp Ther; 2009 Nov; 331(2):340-8. PubMed ID: 19667132
[TBL] [Abstract][Full Text] [Related]
20. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
Fronik P; Gaiser BI; Sejer Pedersen D
J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
